无监督与规则表型方法对比ICD编码识别系统性硬化症
单中心回顾性研究评估无监督主成分线性组合(LPC)、规则表型风险评分(PheRS)与M34 ICD编码计数识别系统性硬化症(SSc)及预测死亡的表现。653例至少一个M34编码患者中547例(84%)经风湿科诊断SSc。LPC在识别SSc上略优于PheRS和编码计数,但LPC与PheRS在预测死亡上明显优于编码计数。
要点
- 至少两个M34编码识别SSc的敏感性87.8%、阳性预测值87.0%。
- LPC与PheRS在SSc患者中预测死亡的AUROC分别为0.74与0.72,高于编码计数的0.63。
- 在至少一个M34编码人群中,LPC识别SSc的AUROC仅0.72,略高于PheRS和编码计数的0.70。
核心结论
- M34编码计数识别SSc的表现合理,与LPC和PheRS相当。
- LPC和PheRS在SSc患者中预测死亡的表现优于M34编码计数。
研究设计与样本
- 单中心回顾性研究,利用电子健康记录数据开发SSc特异性PheRS和LPC评分,使用17个临床特征。
- 研究纳入653例至少有一个M34编码的患者,其中547例(84%)为风湿科诊断的SSc。
主要发现
- 与随机抽样匹配对照相比,LPC识别风湿科诊断SSc的AUROC为0.90,PheRS为0.87。
- 在至少一个M34编码人群的三方法比较中,LPC区分SSc与M34非SSc对照的AUROC为0.72,PheRS为0.70,ICD编码计数为0.70。
- 至少两个M34编码识别SSc的敏感性为87.8%,阳性预测值为87.0%。
- 在SSc患者中预测死亡,LPC、PheRS和M34编码计数的AUROC分别为0.74、0.72和0.63。
关键数值与推荐
- 至少两个M34编码识别SSc的敏感性87.8%、阳性预测值87.0%。
- LPC识别SSc的AUROC为0.90(对比随机匹配对照),PheRS为0.87。
- 三方法比较中LPC、PheRS和ICD编码计数识别SSc的AUROC分别为0.72、0.70和0.70。
- 预测死亡时LPC、PheRS和M34编码计数的AUROC分别为0.74、0.72和0.63。
临床怎么用
- 在风湿免疫科电子病历表型分析中,M34编码计数可用于SSc识别,性能与LPC和PheRS相当。
- 若需预测SSc患者死亡风险,LPC和PheRS较M34编码计数提供更好的判别能力。
局限性
- 单中心回顾性研究,结果外推需谨慎。
- 研究基于至少一个M34编码的人群,未涵盖无该编码的SSc患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our study aims to evaluate the performance of an unsupervised machine learning approach, linear combinations of principal components (LPC); a rule-based approach, phenotype risk score (PheRS); and M34 International Classification of Disease (ICD) code counts for identifying systemic sclerosis (SSc) and predicting mortality from electronic health record (EHR). METHODS: We conducted a single-center retrospective study. We developed SSc-specific PheRS and LPC score using 17 clinical features. We then evaluated these methods for identifying rheumatologist-diagnosed SSc and predict mortality. RESULTS: Of 653 patients with at least one M34 code, 547 (84%) had rheumatologist-diagnosed SSc. When compared with randomly sampled matched controls, LPC outperformed PheRS in identifying rheumatologist-diagnosed SSc (AUROC 0.90 vs 0.87). However, in a three-method comparison among individuals with at least one M34 code, LPC was only marginally superior to PheRS and M34 code counts in distinguishing rheumatologist-diagnosed SSc from M34 non-SSc controls (AUROC 0.72 for LPC, 0.70 for PheRS and 0.70 for ICD code counts). Using at least two M34 codes had a sensitivity of 87.8% and positive predictive value of 87.0% in identifying SSc. Despite the limited performance gains for SSc identification, both LPC and PheRS had substantially higher performance in predicting mortality compared to M34 code counts in patients with SSc (AUROC 0.74 vs 0.72 vs 0.63). CONCLUSION: M34 code counts achieved reasonable performance for SSc identification and comparable to those of LPC and PheRS. However, both LPC and PheRS demonstrated better performance for predicting mortality compared with M34 code counts in patients with SSc.
引用
- Luo Y, Zhang G, Agarwal A, et al. Evaluating unsupervised and rule-based phenotyping methods versus administrative code counts for systemic sclerosis identification. Semin Arthritis Rheum. 2026. PMID: 42385561. doi:10.1016/j.semarthrit.2026.153033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。